Skip to main content
. 2019 Jun 7;10(6):452. doi: 10.1038/s41419-019-1674-2

Fig. 6. The relationship between SLC35B4 and YAP1 in gastric cancer.

Fig. 6

a Analysis of YAP1 expression in normal tissue and gastric tumor from Derrico Gastric data set (GSE13911, N, normal gastric mucosa, n = 31; T, gastric tumor, n = 38) and SLC35B4 expression from Wang Gastric data set (GSE19826, N, normal gastric mucosa, n = 15; T, gastric tumor, n = 12). b The mRNA expression patterns of YAP1 and SLC35B4 in 450 gastric cancer samples. c Protein levels of YAP1 and SLC35B4 in human GC tumor tissues were monitored by IHC analysis. d The tissue array of 60 human GC tissue samples was analyzed by IHC. The scale bar is 200 µm. The correlation analysis of YAP1 and SLC35B4 was decided by histochemistry score of 60 human GC tissue samples. e The correlation between YAP1 expression and overall survival of gastric cancer patients was analyzed by Kaplan–Meier Plotter. f Survival analysis of TCGA GC patients. The survival days and mRNA expression data of SLC35B4 of 354 gastric cancer patients was downloaded from TCGA. (high expression of SLC35B4 group, n = 102; low expression of SLC35B4 group, n = 252. Expression of SLC35B4 cutoff value was 3.35 FPKM)